Oral Antivirals Market

Oral Antivirals Market By type (Generic, Branded), By drug class (Nucleoside reverse transcriptase inhibitors (NRTI), Neuraminidase inhibitor), By disease indication (Influenza, Hepatitis), By distribution channel & By region - Market Review 2021 - 2031

Analysis of Oral Antivirals market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Free Sample

Global Oral Antivirals Market Outlook

The antiviral drugs are the class of medication used to treat viral infections such as influenza, viral hepatitis, parvovirus infection, herpes virus infections, and human immunodeficiency virus (HIV). The emergence of new viral infections such as picorna virus and coronavirus and particularly, resistance to currently antiviral drugs have led to an increase in the demand for the new antiviral drugs. Many contributing factors have increased the demand for oral antivirals in the market.

According to the UNAIDS statistics, around 38 million people were living with retroviral HIV, and around 1.7 million new cases were found in 2019. While, as of the end of June 2020, around 26 million HIV patients were accessing antiretroviral therapy. Besides, according to the Centers for Disease Control and Prevention (CDC), in 2019 about 13 million flu cases were found.

What was the Impact of the Covid-19 Pandemic on the Growth of the Oral Antivirals Market?

The demand for oral antiviral has been steadily rising as the coronavirus pandemic induced away towards protection and hygiene. To cater for the growing demand for antivirals, the leading manufacturers and the merging players have started to kick the opportunities to tackle the pandemic crisis and shape their position in the competitive oral antivirals market. Government support and manufacturers investment to develop safe and effective novel formulation has projected growth in demand for antivirals in the oral antivirals market.

For instance, in October 2020, USFDA approved the first antiviral drug Veklury (remdesivir) that was authorized under Emergency Use Authorization (EUA). The approval and reissued EUA was granted to Gildead Sciences Inc. Additionally, in June 2020, Glenmark has received approval from the Indian Drug Regulatory authority for manufacturing Favipiravir tablets marketed under the brand Fabiflue for the treatment of mild to moderate coronavirus in India.

Additionally, growing private funding to develop safe and effective formulation has emerged in the market. For instance, in March 2020, the Canadian government granted fund of $214.6 million for coronavirus research.

What are the Key Trends Impacting Growth of the Global Oral Antivirals Market?

The oral antivirals market is rapidly growing in presence of emerging market players and government organizations, to develop novel formulations in the field of biotechnology and life science areas. The growing focus in research & development activities is another trending factor actively adopted by the leading manufacturers and researchers. The new drug approvals to treat viral diseases and fluctuation in the price of the marketed drugs is another key to step to serve lucrative opportunities in the oral antivirals market. For instance, Cipla is expected to launch Favipiravir oral tablet under the brand name of Ciplenza at Rupees 68 per tablet while, FDC Ltd. launched two variants of Favipiravir under the brand names PiFLU and Favenza for Rupees 55 per tablet for both the variants.

The growing shift towards biologics from the therapeutic landscape and growing understanding of molecular mechanism expected to lift the oral antivirals market growth rapidly. The regulatory bodies are recognizing the newly developed product under special drug designation that benefits the vendors that contribute to increasing the sales of oral antiviral drugs fueling the oral antivirals market growth in the coming years.

What are the driving factors that expected to boost the oral antivirals market growth?

The rising prevalence of viral diseases is one of the major factor expected to boost oral antivirals market growth worldwide. Rising investment in research areas to develop an effective treatment solution with ongoing clinical studies expects to propel market growth. The leading companies are entering into mergers and acquisitions to benefit the scope of treatment with new findings like novel immunotherapy drugs or other novel formulations.

Rising large patient population with growing viral disease cases and increasing awareness about the disease are some of the factors influencing the growth of the oral antivirals market. Rising awareness about early diagnosis of disease, increasing healthcare spending in the developing countries and increasing investment by the government and the leading market players are contributing to the growth of the oral antivirals market. The regulatory approvals for special drug designation for treatment, strong R&D pipeline expects to propel the oral antivirals market growth in the coming future.

What are the restraining factors that can hamper the global oral antivirals market growth?

Lack of knowledge to follow the regimen, lack of efficacy due to the first-pass metabolism, rising adverse like nausea, vomiting, rash, fever, gastrointestinal discomfort, or other side effects expected to impede the growth of the oral antivirals market during the forecast period. The lengthy method of drug development and high cost for the study is another restraining factor that can hamper the oral antivirals market growth.

Competitive Landscape

Key players such as

Novartis AG
Abbvie Inc.
GlaxoSmithKline
Merck & Co.Inc.
Bristol-Myers Squibb Company
Mylan N.V.
Gilead Sciences Inc.
Janssen Pharmaceuticals Inc.
Appili Therapeutics
Boston biotech Atea Pharmaceutical
others

are actively involved in oral antivirals market.

What strategies are the Key Players adopting to increase their market share in the Oral Antivirals Market?

The established manufacturers are exploring opportunities in developing nations like India, China to enhance their revenue gains by highly investing in research areas to innovate progressive solutions for the oral antivirals market.

The companies are actively focusing on novel drug development, new product launches. The leading companies are actively participating in collaborative agreements and acquisitions to increase their oral antivirals market penetration and shape their position in the leading oral antivirals market. Additionally, the companies are actively entering into strategic distribution agreements to expand their sales footprint worldwide

For instance, in August 2020, Dr Reddy’s generic drug manufacturer launched Avigan (favipiravir) tablets, an antiviral drug that is currently being manufactured by Fujifilm Toyama Chemical Co., a leading Japanese company. The drug was developed to treat mild to moderate Covid-19 patients in India.

Additionally, in October 2020, Roche collaborated with Boston biotech Atea Pharmaceuticals to accelerate the development and manufacturing of antivirals overseas. Under this collaboration, Roche invested $350 million to develop the partial rights to develop an oral antiviral drug with Atea to treat COVID-19.

What are the Key Opportunities in Oral Antivirals Market?

The various pharmaceutical companies are focusing on research areas to capture the unmet needs of the highly effective treatment to provide long-term effective treatment. Concurrently, investments for increasing the production of oral antivirals drugs are exploring opportunities for the key players.

Why North America is dominating the Oral Antivirals Market?

North America is dominating the oral antivirals market owing to the increasing prevalence of retroviral diseases among the growing c population including the bisexual, men and women. The strong R&D background with increased healthcare expenditure has raised the region to dominate the oral antivirals market. The rising cases of HIV among the growing population have elevated the demand for oral antiviral drugs in the market.

The presence of leading manufacturers like Abbvie, Inc., Gilead Sciences Inc., Merck & Co., Inc. and many other players has uplifted the oral antivirals market by highly investing in research efforts to innovate and develop effective products to meet the global needs. According to the Centers for Disease Control and Prevention (CDC) around 1.2 million people were infected with HIV at the end of 2018 in the U.S. Of those, the gay, bisexual, and other men accounted for 69% of all new HIV diagnoses. HIV continues to have an inconsistent impact on the growing population, particularly in ethnic minorities, racial, gays and bisexual men.

The research report on the oral antivirals market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on the market provides analysis and information according to market segments such as drug class, disease indications, and distribution channels.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argetina)
Europe (Germany, Italy, France, U.K, Spain, Russia, BENELUX)
East Asia (China, Japan, South Korea)
South Asia (India, ASEAN)
Oceania (Australia, New Zealand)
Middle East and Africa (GCC Countries, South Africa, Turkey)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Key Segments of global oral antivirals market Covered in the Report

Based on type, the oral antivirals market has been segmented as

Generic
Branded

Based on drug class, the oral antivirals market has been segmented as

Nucleoside reverse transcriptase inhibitors (NRTI)
Neuraminidase inhibitor
Nucleoside analogues of guanine
Nucleoside analogues of thymidine
Protease Inhibitors
Nucleotide reverse transcriptase inhibitor (NtRTI)
Combination Drugs
Others

Based on disease indication, the oral antivirals market has been segmented as

Influenza
Hepatitis
Human Immunodeficiency Virus (HIV)
Coronavirus
Others

Based on distribution channel, the oral antivirals market has been segmented as

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Based on the region, the oral antivirals market has been segmented as

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Why branded segment accounted highest share in the Oral Antivirals Market?

The branded medicines gained popularity in oral antivirals market and accounted highest share owing to the higher adoption of the branded medicines over the generic. The growing shift towards branded medicines with a belief to be safer than generic medicines has surge the demand for the branded medicines.

Why the Hepatitis segment dominated the Oral Antivirals Market?

The hepatitis segments gained dominated the oral antivirals market and accounted highest share owing to the rising prevalence of Hepatitis diseases among the growing population that has surged the demand for the oral antiviral drugs.

According to the Nation Institute of Health (NIH) study, about 2.3 billion people are infected with one or more of the hepatitis viruses worldwide. The viral hepatitis results in around 1.4 million fatals each year, HBV and HCV are responsible for about 90% of these deaths, while the remaining 10% of deaths are caused by other hepatitis viruses.

Table of Content

Executive Summary - Oral Antivirals Market
- Global Market Outlook
- Demand-side Trends
- Supply-side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Inclusion and Exclusion
Value Added Insights
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
  - Supply Side Participants and their Roles
    - Producers
    - Mid-Level Participants (Traders/ Agents/ Brokers)
    - Wholesalers and Distributors
  - Value Added and Value Created at Node in the Supply Chain
  - List of Raw Material Suppliers
  - List of Existing and Potential Buyers
- Pricing Analysis of Oral Antivirals Market
  - Pricing Analysis By Region
  - Pricing Analysis By Country
  - Pricing Analysis By End Use
  - Pricing Analysis By Distributor
  - Pricing Analysis By Application
- Value Chain Analysis
  - Profit Margin Analysis
  - Wholesalers and Distributors
  - Retailers
- Product Portfolio Analysis
- Regulatory Landscape
  - By Key Regions
  - By Key Countries
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Investment Feasibility Matrix
- PESTLE Analysis
  - Political Factors
    - Government stability and change
    - Taxation policy and incentives
    - Trade tariffs and import/export regulations
    - Political risk and corruption levels
  - Economic Factors
    - GDP growth and economic cycles
    - Inflation and interest rates
    - Exchange rate fluctuations
    - Unemployment and consumer spending power
  - Social Factors
    - Demographic trends (age, population growth)
    - Cultural attitudes and lifestyle changes
    - Education levels and workforce skills
    - Health consciousness and social values
  - Technological Factors
    - Rate of technological innovation
    - R&D activity and automation trends
    - Digital infrastructure and connectivity
    - Intellectual property protection
  - Legal Factors
    - Employment and labor laws
    - Health & safety regulations
    - Consumer protection laws
    - Data privacy and antitrust legislation
  - Environmental Factors
    - Environmental regulations and compliance
    - Climate change impacts and carbon footprint
    - Resource availability and sustainability practices
    - Waste management and recycling initiatives
- Market Background and Dynamics
  - Market Dynamics
    - Drivers
    - Restraints
    - Opportunity
    - Trends
  - SWOT Analysis of Global Oral Antivirals Market
    - Strengths
    - Weaknesses
    - Opportunities
    - Threats
Global Oral Antivirals Market Analysis 2020-2024 and Forecast, 2025-2035
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Projections, 2025-2035
  - Y-o-Y Growth Trend Analysis
  - Absolute $ Opportunity Analysis
- Revenue Forecast Scenario, 2020-2035
  - Conservative Scenario
  - Likely Scenario
  - Optimistic Scenario
Global Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035, By Application
- Introduction / Key Findings
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis By Application, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By Application, 2025-2035
- Y-o-Y Growth Trend Analysis By Application, 2020-2024
- Absolute $ Opportunity Analysis By Application, 2025-2035
- Market Attractiveness Analysis By Application, 2025-2035
Global Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035, By End Use
- Introduction / Key Findings
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis By End Use, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By End Use, 2025-2035
- Y-o-Y Growth Trend Analysis By End Use, 2020-2024
- Absolute $ Opportunity Analysis By End Use, 2025-2035
- Market Attractiveness Analysis By End Use, 2025-2035
Global Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035, By Region
- Introduction
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis By Region, 2020-2024
- Current Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By Region, 2025-2035
  - North America
  - Latin America
  - Western Europe
  - Eastern Europe
  - East Asia
  - South Asia and Pacific & Pacific
  - MEA
- Market Attractiveness Analysis By Region
North America Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035
- Introduction
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2025-2035
- By Country
  - USA
  - Canada
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - USA Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Canada Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Mexico Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Latin America Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Brazil
  - Argentina
  - Chile
  - Rest of Latin America
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Brazil Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Argentina Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Chile Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of Latin America Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Western Europe Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Germany
  - UK
  - Italy
  - Spain
  - France
  - Nordic
  - BENELUX
  - Rest of Western Europe
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Germany Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - UK Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Italy Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Spain Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - France Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Nordic Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - BENELUX Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of Western Europe Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Eastern Europe Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Russia
  - Poland
  - Hungary
  - Balkan & Baltic
  - Rest of Eastern Europe
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Russia Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Poland Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Hungary Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Balkan & Baltic Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of Eastern Europe Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
East Asia Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - China
  - Japan
  - South Korea
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - China Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Japan Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - South Korea Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
South Asia and Pacific Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - India
  - ASEAN
  - Australia & New Zealand
  - Rest of South Asia and Pacific
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - India Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - ASEAN Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Australia & New Zealand Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of South Asia and Pacific Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
MEA Oral Antivirals Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Kingdom of Saudi Arabia
  - Other GCC Countries
  - Turkiye
  - South Africa
  - Other African Union
  - Rest of Middle East & Africa
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Kingdom of Saudi Arabia Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Other GCC Countries Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Turkiye Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - South Africa Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - South Africa Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of MEA Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of MEA Oral Antivirals Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
  - By Region
  - By Application
  - By End Use
- Competition Analysis
- Competition Deep Dive
  - Global Key Players
  - Key Players by Region
  - Key Players by Country
Assumptions & Acronyms Used
Research Methodology

List Of Table

Table 1: Global Oral Antivirals Market Value (US$ Mn) Forecast by Region, 2020-2035
Table 2: Global Oral Antivirals Market Volume (Units) Forecast by Region, 2020-2035
Table 3: Global Oral Antivirals Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 4: Global Oral Antivirals Market Volume (Units) Forecast by Application, 2020-2035
Table 5: Global Oral Antivirals Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 6: Global Oral Antivirals Market Volume (Units) Forecast by End Use, 2020-2035
Table 7: North America Oral Antivirals Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 8: North America Oral Antivirals Market Volume (Units) Forecast by Country, 2020-2035
Table 9: North America Oral Antivirals Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 10: North America Oral Antivirals Market Volume (Units) Forecast by Application, 2020-2035
Table 11: North America Oral Antivirals Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 12: North America Oral Antivirals Market Volume (Units) Forecast by End Use, 2020-2035
Table 13: Latin America Oral Antivirals Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 14: Latin America Oral Antivirals Market Volume (Units) Forecast by Country, 2020-2035
Table 15: Latin America Oral Antivirals Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 16: Latin America Oral Antivirals Market Volume (Units) Forecast by Application, 2020-2035
Table 17: Latin America Oral Antivirals Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 18: Latin America Oral Antivirals Market Volume (Units) Forecast by End Use, 2020-2035
Table 19: Europe Oral Antivirals Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 20: Europe Oral Antivirals Market Volume (Units) Forecast by Country, 2020-2035
Table 21: Europe Oral Antivirals Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 22: Europe Oral Antivirals Market Volume (Units) Forecast by Application, 2020-2035
Table 23: Europe Oral Antivirals Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 24: Europe Oral Antivirals Market Volume (Units) Forecast by End Use, 2020-2035
Table 25: East Asia Oral Antivirals Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 26: East Asia Oral Antivirals Market Volume (Units) Forecast by Country, 2020-2035
Table 27: East Asia Oral Antivirals Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 28: East Asia Oral Antivirals Market Volume (Units) Forecast by Application, 2020-2035
Table 29: East Asia Oral Antivirals Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 30: East Asia Oral Antivirals Market Volume (Units) Forecast by End Use, 2020-2035
Table 31: South Asia Oral Antivirals Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 32: South Asia Oral Antivirals Market Volume (Units) Forecast by Country, 2020-2035
Table 33: South Asia Oral Antivirals Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 34: South Asia Oral Antivirals Market Volume (Units) Forecast by Application, 2020-2035
Table 35: South Asia Oral Antivirals Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 36: South Asia Oral Antivirals Market Volume (Units) Forecast by End Use, 2020-2035
Table 37: Oceania Oral Antivirals Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 38: Oceania Oral Antivirals Market Volume (Units) Forecast by Country, 2020-2035
Table 39: Oceania Oral Antivirals Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 40: Oceania Oral Antivirals Market Volume (Units) Forecast by Application, 2020-2035
Table 41: Oceania Oral Antivirals Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 42: Oceania Oral Antivirals Market Volume (Units) Forecast by End Use, 2020-2035
Table 43: MEA Oral Antivirals Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 44: MEA Oral Antivirals Market Volume (Units) Forecast by Country, 2020-2035
Table 45: MEA Oral Antivirals Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 46: MEA Oral Antivirals Market Volume (Units) Forecast by Application, 2020-2035
Table 47: MEA Oral Antivirals Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 48: MEA Oral Antivirals Market Volume (Units) Forecast by End Use, 2020-2035

List Of Figures

Figure 1: Global Oral Antivirals Market Value (US$ Mn) by Application, 2020-2035
Figure 2: Global Oral Antivirals Market Value (US$ Mn) by End Use, 2020-2035
Figure 3: Global Oral Antivirals Market Value (US$ Mn) by Region, 2020-2035
Figure 4: Global Oral Antivirals Market Value (US$ Mn) Analysis by Region, 2020-2035
Figure 5: Global Oral Antivirals Market Volume (Units) Analysis by Region, 2020-2035
Figure 6: Global Oral Antivirals Market Value Share (%) and BPS Analysis by Region, 2020-2035
Figure 7: Global Oral Antivirals Market Y-o-Y Growth (%) Projections by Region, 2020-2035
Figure 8: Global Oral Antivirals Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 9: Global Oral Antivirals Market Volume (Units) Analysis by Application, 2020-2035
Figure 10: Global Oral Antivirals Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 11: Global Oral Antivirals Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 12: Global Oral Antivirals Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 13: Global Oral Antivirals Market Volume (Units) Analysis by End Use, 2020-2035
Figure 14: Global Oral Antivirals Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 15: Global Oral Antivirals Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 16: Global Oral Antivirals Market Attractiveness by Application, 2020-2035
Figure 17: Global Oral Antivirals Market Attractiveness by End Use, 2020-2035
Figure 18: Global Oral Antivirals Market Attractiveness by Region, 2020-2035
Figure 19: North America Oral Antivirals Market Value (US$ Mn) by Application, 2020-2035
Figure 20: North America Oral Antivirals Market Value (US$ Mn) by End Use, 2020-2035
Figure 21: North America Oral Antivirals Market Value (US$ Mn) by Country, 2020-2035
Figure 22: North America Oral Antivirals Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 23: North America Oral Antivirals Market Volume (Units) Analysis by Country, 2020-2035
Figure 24: North America Oral Antivirals Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 25: North America Oral Antivirals Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 26: North America Oral Antivirals Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 27: North America Oral Antivirals Market Volume (Units) Analysis by Application, 2020-2035
Figure 28: North America Oral Antivirals Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 29: North America Oral Antivirals Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 30: North America Oral Antivirals Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 31: North America Oral Antivirals Market Volume (Units) Analysis by End Use, 2020-2035
Figure 32: North America Oral Antivirals Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 33: North America Oral Antivirals Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 34: North America Oral Antivirals Market Attractiveness by Application, 2020-2035
Figure 35: North America Oral Antivirals Market Attractiveness by End Use, 2020-2035
Figure 36: North America Oral Antivirals Market Attractiveness by Country, 2020-2035
Figure 37: Latin America Oral Antivirals Market Value (US$ Mn) by Application, 2020-2035
Figure 38: Latin America Oral Antivirals Market Value (US$ Mn) by End Use, 2020-2035
Figure 39: Latin America Oral Antivirals Market Value (US$ Mn) by Country, 2020-2035
Figure 40: Latin America Oral Antivirals Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 41: Latin America Oral Antivirals Market Volume (Units) Analysis by Country, 2020-2035
Figure 42: Latin America Oral Antivirals Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 43: Latin America Oral Antivirals Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 44: Latin America Oral Antivirals Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 45: Latin America Oral Antivirals Market Volume (Units) Analysis by Application, 2020-2035
Figure 46: Latin America Oral Antivirals Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 47: Latin America Oral Antivirals Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 48: Latin America Oral Antivirals Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 49: Latin America Oral Antivirals Market Volume (Units) Analysis by End Use, 2020-2035
Figure 50: Latin America Oral Antivirals Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 51: Latin America Oral Antivirals Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 52: Latin America Oral Antivirals Market Attractiveness by Application, 2020-2035
Figure 53: Latin America Oral Antivirals Market Attractiveness by End Use, 2020-2035
Figure 54: Latin America Oral Antivirals Market Attractiveness by Country, 2020-2035
Figure 55: Europe Oral Antivirals Market Value (US$ Mn) by Application, 2020-2035
Figure 56: Europe Oral Antivirals Market Value (US$ Mn) by End Use, 2020-2035
Figure 57: Europe Oral Antivirals Market Value (US$ Mn) by Country, 2020-2035
Figure 58: Europe Oral Antivirals Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 59: Europe Oral Antivirals Market Volume (Units) Analysis by Country, 2020-2035
Figure 60: Europe Oral Antivirals Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 61: Europe Oral Antivirals Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 62: Europe Oral Antivirals Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 63: Europe Oral Antivirals Market Volume (Units) Analysis by Application, 2020-2035
Figure 64: Europe Oral Antivirals Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 65: Europe Oral Antivirals Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 66: Europe Oral Antivirals Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 67: Europe Oral Antivirals Market Volume (Units) Analysis by End Use, 2020-2035
Figure 68: Europe Oral Antivirals Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 69: Europe Oral Antivirals Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 70: Europe Oral Antivirals Market Attractiveness by Application, 2020-2035
Figure 71: Europe Oral Antivirals Market Attractiveness by End Use, 2020-2035
Figure 72: Europe Oral Antivirals Market Attractiveness by Country, 2020-2035
Figure 73: East Asia Oral Antivirals Market Value (US$ Mn) by Application, 2020-2035
Figure 74: East Asia Oral Antivirals Market Value (US$ Mn) by End Use, 2020-2035
Figure 75: East Asia Oral Antivirals Market Value (US$ Mn) by Country, 2020-2035
Figure 76: East Asia Oral Antivirals Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 77: East Asia Oral Antivirals Market Volume (Units) Analysis by Country, 2020-2035
Figure 78: East Asia Oral Antivirals Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 79: East Asia Oral Antivirals Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 80: East Asia Oral Antivirals Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 81: East Asia Oral Antivirals Market Volume (Units) Analysis by Application, 2020-2035
Figure 82: East Asia Oral Antivirals Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 83: East Asia Oral Antivirals Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 84: East Asia Oral Antivirals Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 85: East Asia Oral Antivirals Market Volume (Units) Analysis by End Use, 2020-2035
Figure 86: East Asia Oral Antivirals Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 87: East Asia Oral Antivirals Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 88: East Asia Oral Antivirals Market Attractiveness by Application, 2020-2035
Figure 89: East Asia Oral Antivirals Market Attractiveness by End Use, 2020-2035
Figure 90: East Asia Oral Antivirals Market Attractiveness by Country, 2020-2035
Figure 91: South Asia Oral Antivirals Market Value (US$ Mn) by Application, 2020-2035
Figure 92: South Asia Oral Antivirals Market Value (US$ Mn) by End Use, 2020-2035
Figure 93: South Asia Oral Antivirals Market Value (US$ Mn) by Country, 2020-2035
Figure 94: South Asia Oral Antivirals Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 95: South Asia Oral Antivirals Market Volume (Units) Analysis by Country, 2020-2035
Figure 96: South Asia Oral Antivirals Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 97: South Asia Oral Antivirals Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 98: South Asia Oral Antivirals Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 99: South Asia Oral Antivirals Market Volume (Units) Analysis by Application, 2020-2035
Figure 100: South Asia Oral Antivirals Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 101: South Asia Oral Antivirals Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 102: South Asia Oral Antivirals Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 103: South Asia Oral Antivirals Market Volume (Units) Analysis by End Use, 2020-2035
Figure 104: South Asia Oral Antivirals Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 105: South Asia Oral Antivirals Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 106: South Asia Oral Antivirals Market Attractiveness by Application, 2020-2035
Figure 107: South Asia Oral Antivirals Market Attractiveness by End Use, 2020-2035
Figure 108: South Asia Oral Antivirals Market Attractiveness by Country, 2020-2035
Figure 109: Oceania Oral Antivirals Market Value (US$ Mn) by Application, 2020-2035
Figure 110: Oceania Oral Antivirals Market Value (US$ Mn) by End Use, 2020-2035
Figure 111: Oceania Oral Antivirals Market Value (US$ Mn) by Country, 2020-2035
Figure 112: Oceania Oral Antivirals Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 113: Oceania Oral Antivirals Market Volume (Units) Analysis by Country, 2020-2035
Figure 114: Oceania Oral Antivirals Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 115: Oceania Oral Antivirals Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 116: Oceania Oral Antivirals Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 117: Oceania Oral Antivirals Market Volume (Units) Analysis by Application, 2020-2035
Figure 118: Oceania Oral Antivirals Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 119: Oceania Oral Antivirals Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 120: Oceania Oral Antivirals Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 121: Oceania Oral Antivirals Market Volume (Units) Analysis by End Use, 2020-2035
Figure 122: Oceania Oral Antivirals Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 123: Oceania Oral Antivirals Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 124: Oceania Oral Antivirals Market Attractiveness by Application, 2020-2035
Figure 125: Oceania Oral Antivirals Market Attractiveness by End Use, 2020-2035
Figure 126: Oceania Oral Antivirals Market Attractiveness by Country, 2020-2035
Figure 127: MEA Oral Antivirals Market Value (US$ Mn) by Application, 2020-2035
Figure 128: MEA Oral Antivirals Market Value (US$ Mn) by End Use, 2020-2035
Figure 129: MEA Oral Antivirals Market Value (US$ Mn) by Country, 2020-2035
Figure 130: MEA Oral Antivirals Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 131: MEA Oral Antivirals Market Volume (Units) Analysis by Country, 2020-2035
Figure 132: MEA Oral Antivirals Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 133: MEA Oral Antivirals Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 134: MEA Oral Antivirals Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 135: MEA Oral Antivirals Market Volume (Units) Analysis by Application, 2020-2035
Figure 136: MEA Oral Antivirals Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 137: MEA Oral Antivirals Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 138: MEA Oral Antivirals Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 139: MEA Oral Antivirals Market Volume (Units) Analysis by End Use, 2020-2035
Figure 140: MEA Oral Antivirals Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 141: MEA Oral Antivirals Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 142: MEA Oral Antivirals Market Attractiveness by Application, 2020-2035
Figure 143: MEA Oral Antivirals Market Attractiveness by End Use, 2020-2035
Figure 144: MEA Oral Antivirals Market Attractiveness by Country, 2020-2035

Oral Antivirals Market

Schedule a Call